Clinical Trial Update: HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

View source ↗

Summary

A clinical trial is evaluating whether modulation of HO-1 and CREB3 influences Golgi stress in patients with sepsis and is currently in the recruiting phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Tianjin Nankai Hospital | Conditions: Sepsis | Status: RECRUITING